1. Percival Yang-Ting Chen
  2. Elizabeth C Wittenborn
  3. Catherine L Drennan  Is a corresponding author
  1. Massachusetts Institute of Technology, United States

Nitrogen is an element that is found in nearly all important biological molecules, including amino acids and nucleic acids. Nitrogen is also abundant in our atmosphere in the form of N2 molecules, but this form of the element cannot be used biologically, so N2 must be transformed or “fixed” into biologically reactive compounds such as ammonia (NH3) and nitrate (NO3-).

Nature employs enzymes called nitrogenases to fix nitrogen. These enzymes rely on “cofactors” to perform their chemistry: the most widely studied of these cofactors contains iron and molybdenum, and hence is called the FeMo-cofactor (Figure 1). Despite the fact that nitrogenase activity was discovered in 1934, a comprehensive understanding of how it works has remained elusive due to the intrinsic complexity of both the FeMo-cofactor and the nitrogen fixation reaction (Hoffman et al., 2014). Now, in eLife, Thomas Spatzal, Kathryn Perez, James Howard and Douglas Rees report that some of the atoms that make up the FeMo-cofactor migrate in unexpected ways during catalysis (Spatzal et al., 2015).

The FeMo-cofactor contains a [7Fe-9S-C-Mo] center (right) coordinated to (R)-homocitrate (left) (Kim and Rees, 1992; Einsle et al., 2002; Spatzal et al., 2011).

Spatzal, Perez et al. were able to insert a selenium atom into the S2B position of the FeMo-cofactor, and track how it moves during catalysis. Iron (Fe) atoms are shown in orange, sulfur (S) atoms in yellow, carbon in gray, molybdenum in cyan, and oxygen in red. The overall reaction is also shown. Reduction of each nitrogen molecule (N2), requires eight electrons and at least eight protons (H+), yielding two ammonia molecules (NH3) and one hydrogen molecule (H2). This nitrogen fixation reaction is coupled to the hydrolysis of 16 adenosine triphosphate (ATP) molecules (Burgess and Lowe, 1996; Howard and Rees, 2006; Hoffman et al., 2014).

Molybdenum nitrogenase is an enzyme that contains a molybdenum-iron protein (which is catalytic) and an iron protein (which is involved in electron transfer). The molybdenum-iron protein is home to the FeMo-cofactor and a cluster of iron and sulfur atoms that transfers electrons between the iron protein and the FeMo-cofactor. During the reaction cycle, the FeMo-cofactor orchestrates the reduction of two distinct substrates, N2 and H+, and allocates hydrogen atoms into products (NH3 or H2). Elucidating a detailed mechanism for this process is important for understanding how molybdenum nitrogenase is able to achieve this challenging chemical transformation.

To clarify how substrates bind to the FeMo-cofactor, Rees and co-workers previously solved a high-resolution X-ray crystal structure of the molybdenum-iron protein bound to carbon monoxide, a molecule that inhibits the cofactor (Spatzal et al., 2014). Unexpectedly, this structure revealed that carbon monoxide replaces the sulfur atom at the S2B position in the FeMo-cofactor; this atom is one of three "belt sulfurs" that form bridges between pairs of iron atoms in the cofactor (Figure 1). Significantly, this process is reversible; reactivated molybdenum-iron protein was shown to once again contain sulfur in the S2B position. These structures serve to shed light on substrate binding in molybdenum nitrogenase and suggest a previously unanticipated kinetic instability, or lability, of the FeMo-cofactor.

Inspired by this apparent lability of the FeMo-cofactor, Spatzal, Perez et al. – who are based at the California Institute of Technology and the University of Minnesota – have now developed a means of labeling the S2B site of the FeMo-cofactor with selenium, the element immediately below sulfur in the periodic table. Selenocyanate is a compound that contains selenium, and has recently been identified as a substrate and inhibitor of nitrogenase. Spatzal, Perez et al. therefore used X-ray crystallography to identify changes in the molybdenum-iron protein after nitrogenase had reacted with selenocyanate. In particular, they used the fact that selenium scatters X-rays differently from sulfur to confirm that selenium replaces sulfur at the S2B position, further strengthening the notion that S2B is a labile element in the FeMo-cofactor.

Spatzal, Perez et al. then showed that incorporating selenium into the FeMo-cofactor does not alter the catalytic activity of the enzyme. Taking a series of crystallographic snapshots of the selenium-containing cofactor at different stages of catalysis revealed that under turnover conditions, selenium migrates to the other two belt-sulfur positions. Selenium is then replaced by sulfur after reacting with multiple substrates. However, this migration of selenium is only observed when N2 or acetylene (C2H2) are used as substrates, and not when H+ is the exclusive substrate.

Before this work, the dogma in the field was that the atoms in the FeMo-cofactor and other metallocofactors provide a rigid scaffold on which chemistry can be performed, with movements restricted to protein sidechains, substrates and products. Now we must consider that in nitrogenase – and potentially other enzymes – the atoms of metallocofactors may actively change positions and that this dynamic nature may be substrate-specific.

The work of Spatzal, Perez et al. raises many additional questions. For example, how does belt-sulfur migration correlate with the reaction mechanism? And how are the structural dynamics of the FeMo-cofactor coupled to the reduction of different substrates? It also provides a powerful tool for interrogating the FeMo-cofactor through site-specific selenium incorporation. Already this method has allowed us to see selenium waltzing around the FeMo-cofactor center, and it is hard to imagine what surprises this enzyme has in store for us next.

References

Article and author information

Author details

  1. Percival Yang-Ting Chen

    Department of Chemistry, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Elizabeth C Wittenborn

    Department of Chemistry, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Catherine L Drennan

    Departments of Chemistry and Biology and the Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States
    For correspondence
    cdrennan@mit.edu
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published: February 3, 2016 (version 1)

Copyright

© 2016, Chen et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,038
    Page views
  • 129
    Downloads
  • 2
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Percival Yang-Ting Chen
  2. Elizabeth C Wittenborn
  3. Catherine L Drennan
(2016)
Nitrogen Fixation: Waltzing around cofactors
eLife 5:e13977.
https://doi.org/10.7554/eLife.13977

Further reading

    1. Biochemistry and Chemical Biology
    2. Plant Biology
    Dietmar Funck, Malte Sinn ... Jörg S Hartig
    Research Article

    Metabolism and biological functions of the nitrogen-rich compound guanidine have long been neglected. The discovery of four classes of guanidine-sensing riboswitches and two pathways for guanidine degradation in bacteria hint at widespread sources of unconjugated guanidine in nature. So far, only three enzymes from a narrow range of bacteria and fungi have been shown to produce guanidine, with the ethylene-forming enzyme (EFE) as the most prominent example. Here, we show that a related class of Fe2+- and 2-oxoglutarate-dependent dioxygenases (2-ODD-C23) highly conserved among plants and algae catalyze the hydroxylation of homoarginine at the C6-position. Spontaneous decay of 6-hydroxyhomoarginine yields guanidine and 2-aminoadipate-6-semialdehyde. The latter can be reduced to pipecolate by pyrroline-5-carboxylate reductase but more likely is oxidized to aminoadipate by aldehyde dehydrogenase ALDH7B in vivo. Arabidopsis has three 2-ODD-C23 isoforms, among which Din11 is unusual because it also accepted arginine as substrate, which was not the case for the other 2-ODD-C23 isoforms from Arabidopsis or other plants. In contrast to EFE, none of the three Arabidopsis enzymes produced ethylene. Guanidine contents were typically between 10 and 20 nmol*(g fresh weight)-1 in Arabidopsis but increased to 100 or 300 nmol*(g fresh weight)-1 after homoarginine feeding or treatment with Din11-inducing methyljasmonate, respectively. In 2-ODD-C23 triple mutants, the guanidine content was strongly reduced, whereas it increased in overexpression plants. We discuss the implications of the finding of widespread guanidine-producing enzymes in photosynthetic eukaryotes as a so far underestimated branch of the bio-geochemical nitrogen cycle and propose possible functions of natural guanidine production.

    1. Biochemistry and Chemical Biology
    2. Medicine
    Giulia Leanza, Francesca Cannata ... Nicola Napoli
    Research Article

    Type 2 diabetes (T2D) is associated with higher fracture risk, despite normal or high bone mineral density. We reported that bone formation genes (SOST and RUNX2) and advanced glycation end-products (AGEs) were impaired in T2D. We investigated Wnt signaling regulation and its association with AGEs accumulation and bone strength in T2D from bone tissue of 15 T2D and 21 non-diabetic postmenopausal women undergoing hip arthroplasty. Bone histomorphometry revealed a trend of low mineralized volume in T2D (T2D 0.249% [0.156–0.366]) vs non-diabetic subjects 0.352% [0.269–0.454]; p=0.053, as well as reduced bone strength (T2D 21.60 MPa [13.46–30.10] vs non-diabetic subjects 76.24 MPa [26.81–132.9]; p=0.002). We also showed that gene expression of Wnt agonists LEF-1 (p=0.0136) and WNT10B (p=0.0302) were lower in T2D. Conversely, gene expression of WNT5A (p=0.0232), SOST (p<0.0001), and GSK3B (p=0.0456) were higher, while collagen (COL1A1) was lower in T2D (p=0.0482). AGEs content was associated with SOST and WNT5A (r=0.9231, p<0.0001; r=0.6751, p=0.0322), but inversely correlated with LEF-1 and COL1A1 (r=–0.7500, p=0.0255; r=–0.9762, p=0.0004). SOST was associated with glycemic control and disease duration (r=0.4846, p=0.0043; r=0.7107, p=0.00174), whereas WNT5A and GSK3B were only correlated with glycemic control (r=0.5589, p=0.0037; r=0.4901, p=0.0051). Finally, Young’s modulus was negatively correlated with SOST (r=−0.5675, p=0.0011), AXIN2 (r=−0.5523, p=0.0042), and SFRP5 (r=−0.4442, p=0.0437), while positively correlated with LEF-1 (r=0.4116, p=0.0295) and WNT10B (r=0.6697, p=0.0001). These findings suggest that Wnt signaling and AGEs could be the main determinants of bone fragility in T2D.